Granulocyte colony-stimulating factor-induced aortitis with temporal arteritis and monoarthritis

BMJ Case Rep. 2023 Feb 7;16(2):e251216. doi: 10.1136/bcr-2022-251216.

Abstract

We present the case of a patient in his 80s receiving gemcitabine-cisplatin therapy for bladder cancer who developed neutropenia and was treated with filgrastim. In 10 days, the patient developed a mild fever with left jaw claudication and right knee arthritis. Contrast-enhanced CT findings indicated aortitis. Prednisolone was started for granulocyte colony-stimulating factor (G-CSF)-induced aortitis, and symptoms and elevated serum inflammatory markers resolved rapidly, allowing early discontinuation of prednisolone. Right knee arthritis relapsed at the initial follow-up. Contrast-enhanced CT revealed aortitis had disappeared. Therefore, recurrence of G-CSF-induced arthritis was suspected; prednisolone was resumed for 29 days without relapse. Most previous reports of G-CSF-induced aortitis have described inflammation of the aorta, carotid arteries and subclavian arteries; however, G-CSF-induced aortitis may present with more peripheral symptoms, such as temporal arteritis and knee arthritis. Furthermore, G-CSF-induced aortitis reportedly responds well and rapidly to prednisolone, although early discontinuation may lead to relapse.

Keywords: General practice / family medicine; Rheumatology; Unwanted effects / adverse reactions.

Publication types

  • Case Reports

MeSH terms

  • Aortitis* / chemically induced
  • Arthritis*
  • Filgrastim / adverse effects
  • Giant Cell Arteritis*
  • Granulocyte Colony-Stimulating Factor / adverse effects
  • Humans
  • Neoplasm Recurrence, Local
  • Prednisolone / adverse effects

Substances

  • Granulocyte Colony-Stimulating Factor
  • Filgrastim
  • Prednisolone